EuroPCR 2021 | COLOR: Complex PCI via Transradial vs Transfemoral Approach

Treating total occlusions, complex bifurcations, grossly calcified lesions or left main lesions via transradial approach is associated with significant reduction in access-site bleeding or vascular complications vs transfemoral approach. This kind of procedures have been typically excluded from studies randomizing patients to transradial vs transfemoral approach. 

EuroPCR 2021 | COLOR: Angioplastias complejas por acceso radial vs femoral

The COLOR study used the transradial bore-guiding catheter Glidesheath (produced by Terumo) with a much thinner wall that enables the use of 7 French devices in 6 French access sites. 

Guidelines on both sides of the Atlantic recommend the transradial approach over the transfemoral because of its capacity to reduce bleeding, vascular complications and even mortality (RIFLE-STEACS y MATRIX). 

Despite the latter, there are many operators that given the need for a larger bore-guiding catheter, opt for the transfemoral approach. Curiously, choosing one over the other varies according to center, country, and ever operator age. 

The COLOR study was presented at EuroPCR 2021 scientific sessions and was simultaneously published in JACC: Cardiovascular Interventions. It included 388 patients with planned complex PCI requiring 7 French catheters. 

Over half of these procedures were total occlusions (58%), followed by calcified lesions (19%), left main lesions (14%) and 2 stent bifurcations (9%).


Read also: EuroPCR 2021 | TVT Registry: Outcomes of TAVR in Low Surgical Risk Bicuspids.


Procedural success was around 90% in both arms and the use of a different approach to the one indicated by randomization (crossover rate) was low, and similar between arms. 

The combined primary end point of BARC bleeding 2/3/5 or vascular complication requiring intervention, occurred in 19.1% of patients in the transfemoral group vs. 3.6% in the transradial group. The difference in bleeding was basically driven by BARC 2 bleeding (apparent bleeding, but with no clinical compromise). Vascular complications were 4.1% vs 0.5% respectively (p=0.04).

Major cardiovascular events at 30 days showed a tendency in favor of the femoral access (2.6% vs 6.7%; p=0.06). This should be interpreted with caution seeing as the COLOR did not reach the statistical power to show differences in clinical events.  

Original Title: Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention.

Reference: Thomas A Meijers et al. JACC Cardiovasc Interv. 2021 May 7;S1936-8798(21)00513-6. Online ahead of print. doi: 10.1016/j.jcin.2021.03.041.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...